2
项与 CAR-NK Cells(The Second Hospital of Shandong University) 相关的临床试验Clinical Study on the Safety and Efficacy of CAR-T/CAR-NK Cells in the Treatment of Recurrent Refractory or Unresectable Solid Tumors
To investigate the safety and efficacy of CAR-T/CAR-NK cells in patients with recurrent or unresectable solid tumors, including pancreatic cancer, prostate cancer, breast cancer, glioma, etc
Head of Hematology,Vice President and Secretary-General of Shandong Stem Cell Society
To investigate the safety and efficacy of CD19 CAR-T/CAR-NK cells in patients with relapsed/refractory B-cell lymphoma and acute B-lymphoblastic leukemia.
100 项与 CAR-NK Cells(The Second Hospital of Shandong University) 相关的临床结果
100 项与 CAR-NK Cells(The Second Hospital of Shandong University) 相关的转化医学
100 项与 CAR-NK Cells(The Second Hospital of Shandong University) 相关的专利(医药)
100 项与 CAR-NK Cells(The Second Hospital of Shandong University) 相关的药物交易